Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Trial to Address the Safety of the SmartFlow MR-Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Subjects

NCT04903288 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT04903288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04903288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Trial to Address the Safety of the SmartFlow MR-Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Subjects
Lead sponsor
PTC Therapeutics
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 12, 2021
Completion date
April 30, 2028
Enrollment
13 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aadc deficiency